China Medical System Holdings Limited

HKEX:0867.HK

12.98 (HKD) • At close July 22, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) HKD.

2024 Q42024 Q22023 Q42023 Q22022 Q42022 Q22021 Q42021 Q22020 Q42020 Q22019 Q42019 Q22018 Q42018 Q22017 Q42017 Q22016 Q42016 Q22015 Q42015 Q22014 Q42014 Q22013 Q42013 Q22012 Q42012 Q22011 Q42011 Q22010 Q42010 Q22009 Q42009 Q22008 Q42008 Q22007 Q42007 Q22006 Q42006 Q2
Revenue 3,857.9213,611.0693,403.1584,610.1274,702.5564,447.7914,494.2053,843.0163,837.8893,108.0753,109.2642,964.362,778.4422,655.0072,662.4742,686.3642,723.7132,177.0991,877.0271,676.4041,578.3931,366.7381,208.2621,040.73933.917825.437661.16661.16438.34438.34329.293329.293247.71247.71189.008189.008146.761146.761
Cost of Revenue 1,132.227914.569933.0971,004.2371,102.8591,011.6411,121.048969.235997.079814.67780.427746.881745.282771.293846.1431,024.3941,081.327907.584788.862718.473660.657629.846545.627476.986376.772347.678286.822286.822179.329179.329121.525121.52594.97394.97366.2966.2945.63545.635
Gross Profit 2,725.6942,696.52,470.0613,605.893,599.6973,436.153,373.1572,873.7812,840.812,293.4052,328.8372,217.4792,033.161,883.7141,816.3311,661.971,642.3861,269.5151,088.165957.931917.736736.892662.635563.744557.145477.76374.338374.338259.01259.01207.769207.769152.738152.738122.718122.718101.126101.126
Gross Profit Ratio 0.7070.7470.7260.7820.7650.7730.7510.7480.740.7380.7490.7480.7320.7090.6820.6190.6030.5830.580.5710.5810.5390.5480.5420.5970.5790.5660.5660.5910.5910.6310.6310.6170.6170.6490.6490.6890.689
Reseach & Development Expenses 224.407105.575119.39475.7469.8855.55177.91136.8536.16530.35229.61915.4350000000000000000006.9586.9587.7627.7625.9655.9658.8118.811
General & Administrative Expenses 418.588361.505338.644317.984356.936279.676281.576159.419152.19598.985109.73996.497144.73598.53124.72197.253120.164101.5599.70593.01680.84871.04877.57767.94266.47250.93748.20348.20341.20841.20825.2625.2623.67923.67931.87931.87919.82519.825
Selling & Marketing Expenses 1,261.1891,400.4591,171.7211,339.621,442.8521,278.461,496.5791,043.5681,227.661825.5721,057.792881.375937.428735.167784.479597.671713.582460.178461.754352.368381.398249.747277.474190.06215.03144.086135.002135.002102.693102.69384.80484.80463.56963.56950.89450.89451.28451.284
SG&A 1,679.7771,761.9641,510.3651,657.6041,799.7881,558.1361,778.1551,202.9871,379.856924.5571,167.531977.8721,082.163833.697909.2694.924833.746561.728561.459445.384462.246320.795355.051258.002281.502195.023183.205183.205143.901143.901110.064110.06487.24887.24882.77482.77471.10971.109
Other Expenses -82.0430000000000000000000000003.739000000000000
Operating Expenses 1,822.1411,867.5391,629.7591,366.9661,915.361,414.0661,767.2321,076.71,540.976810.6611,136.979907.3821,068.417796.274830.207775.065835.199553.746557.604410.331240.618303.433356.496207.971271.604192.375183.205183.205142.664142.664117.022117.02295.0195.0188.4588.4579.59379.593
Operating Income 903.553828.961840.3021,872.5461,730.0291,822.4631,517.0911,633.9441,424.7891,338.4961,131.6871,224.172950.9971,050.017907.131967.046808.64707.787526.706512.547455.49416.097307.584305.742275.643417.721216.88216.88116.903116.90390.73790.73761.60361.60337.83737.83721.39221.392
Operating Income Ratio 0.2340.230.2470.4060.3680.410.3380.4250.3710.4310.3640.4130.3420.3950.3410.360.2970.3250.2810.3060.2890.3040.2550.2940.2950.5060.3280.3280.2670.2670.2760.2760.2490.2490.20.20.1460.146
Total Other Income Expenses Net -29.582307.375-249.123410.046-22.893233.251123.316182.238-76.1128.90457.45874.38110.247-4.88744.454-110.198-6.644-9.3424.46620.372230.66127.25631.83140.12822.147-3.328-2.935-2.935-0.252-0.252-1.082-1.0828.9268.9263.5213.521-0.402-0.402
Income Before Tax 873.9711,136.336591.1792,282.5921,707.1362,055.7141,640.4071,816.1821,348.6891,467.41,189.1451,298.553961.2441,045.13951.585856.848801.996698.445531.172532.919686.151443.353339.415345.87297.79291.955213.945213.945114.857114.85791.92591.92566.65366.65337.78937.78920.99120.991
Income Before Tax Ratio 0.2270.3150.1740.4950.3630.4620.3650.4730.3510.4720.3820.4380.3460.3940.3570.3190.2940.3210.2830.3180.4350.3240.2810.3320.3190.3540.3240.3240.2620.2620.2790.2790.2690.2690.20.20.1430.143
Income Tax Expense 164.293232.934122.7366.641227.265259.39246.703184.62293.504166.885400.971131.03371.78889.98885.72752.76778.28844.23628.59739.02853.11333.39618.65231.33524.49733.89517.97517.97513.07613.07620.81220.81215.3115.316.1076.1075.5955.595
Net Income 709.362910.426479.8841,921.0561,460.2561,798.7361,389.9211,627.4811,250.9771,279.421790.8161,169.896892.339957.544869.854804.953722.142653.794500.886495.049633.038412.664321.556314.657272.844257.953195.702195.702101.436101.43670.61570.61550.99650.99631.72231.72215.6515.65
Net Income Ratio 0.1840.2520.1410.4170.3110.4040.3090.4230.3260.4120.2540.3950.3210.3610.3270.30.2650.30.2670.2950.4010.3020.2660.3020.2920.3130.2960.2960.2310.2310.2140.2140.2060.2060.1680.1680.1070.107
EPS 0.30.370.1960.780.60.740.560.660.50.520.320.480.360.380.340.320.30.260.20.20.260.1710.1330.130.1130.1070.080.080.050.050.040.040.570.570.390.390.210.21
EPS Diluted 0.30.370.1960.780.60.740.560.660.50.520.320.480.360.380.340.320.30.260.20.20.260.1710.1330.130.1130.1070.080.080.050.050.040.040.570.570.390.390.210.21
EBITDA 1,365.131943.024946.0581,976.0911,834.6191,926.9521,618.7121,738.3721,522.0721,438.2721,227.7161,322.6411,051.3031,148.7051,006.4311,064.164907.298784.988570.058546.946478.093435.942326.47300590.082229.949229.949122.087122.087100.129100.12966.94366.94341.43141.43123.29523.295
EBITDA Ratio 0.3540.2610.2780.4290.390.4330.360.4520.3970.4630.3950.4460.3780.4330.3780.3960.3330.3610.3040.3260.3030.3190.27000.7150.3480.3480.2790.2790.3040.3040.270.270.2190.2190.1590.159